RTI Surgical® Announces 2016 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Craig-Hallum Downgrades RTI Biologics (RTIX) to Hold
July 28, 2016 8:46 AM EDTCraig-Hallum downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00 (from $6.00).
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $3.43 yesterday.
... MoreRTI Surgical (RTIX) Posts Q2 Loss of 5c/Share; Will Conduct Strategic Business Review
July 27, 2016 7:51 AM EDTRTI Surgical (NASDAQ: RTIX) reported Q2 EPS of ($0.05), $0.08 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $67.6 million versus the consensus estimate of $66.52 million.
